Literature DB >> 27637490

Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis.

Saeideh Jafarinejad-Farsangi1, Ali Farazmand2, Farhad Gharibdoost3, Elham Karimizadeh1, Farshid Noorbakhsh4, Habibeh Faridani3, Mahdi Mahmoudi3, Ahmad Reza Jamshidi5.   

Abstract

BACKGROUND: Prolonged activation of dermal fibroblasts is the main cause of progressive fibrosis in systemic sclerosis (SSc). It seems that inhibition of apoptosis in SSc fibroblasts deregulates fibrosis. MicroRNA-21 (miR-21) is a pro-fibrotic factor with high expression in lesional areas of SSc skin and fibroblasts.
METHODS: The effects of miR-21 on expression of Bcl-2 and Bax, two apoptotic genes, in dermal fibroblasts of SSc patients were evaluated using real-time polymerase chain reaction and Western blot analysis. Apoptotic cells were detected using flow cytometry and Hoechst 33258 staining assays.
RESULTS: Overexpression of miR-21 using synthetic miR-21 RNA increased expression of Bcl-2, an inhibitor of apoptosis, and decreased the Bax : Bcl-2 expression ratio, a cell fate determinant, in SSc fibroblasts. Antisense inhibition of miR-21 induced a high rate of apoptosis in SSc fibroblasts. We propose that this may be associated with a decrease in Bcl-2 expression and a shift in the Bax : Bcl-2 ratio.
CONCLUSIONS: Although further studies are necessary to determine the underlying apoptotic pathway, we propose that inhibition of miR-21 in dermal fibroblasts from lesional skin may be useful in harnessing progressive fibrosis in SSc.
© 2016 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27637490     DOI: 10.1111/ijd.13308

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  11 in total

1.  Overexpression of apoptosis-related protein, survivin, in fibroblasts from patients with systemic sclerosis.

Authors:  Mohammad Bagher Mahmoudi; Ehsan Farashahi Yazd; Farhad Gharibdoost; Mohammad Hasan Sheikhha; Elham Karimizadeh; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Ir J Med Sci       Date:  2019-02-13       Impact factor: 1.568

Review 2.  Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives.

Authors:  Pei-Suen Tsou
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

Review 3.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

4.  MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.

Authors:  Xiangguang Shi; Qingmei Liu; Na Li; Wenzhen Tu; Ruoyu Luo; Xueqian Mei; Yanyun Ma; Weihong Xu; Haiyan Chu; Shuai Jiang; Zhimin Du; Han Zhao; Liang Zhao; Li Jin; Wenyu Wu; Jiucun Wang
Journal:  Cell Cycle       Date:  2018-09-17       Impact factor: 4.534

Review 5.  Pathogenesis and treatment of autoimmune rheumatic diseases.

Authors:  Eric Liu; Andras Perl
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

6.  Mir-21 Mediates the Inhibitory Effect of Ang (1-7) on AngII-induced NLRP3 Inflammasome Activation by Targeting Spry1 in lung fibroblasts.

Authors:  Na-Na Sun; Chang-Hui Yu; Miao-Xia Pan; Yue Zhang; Bo-Jun Zheng; Qian-Jie Yang; Ze-Mao Zheng; Ying Meng
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

Review 7.  The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview.

Authors:  Bianca Saveria Fioretto; Irene Rosa; Eloisa Romano; Yukai Wang; Serena Guiducci; Guohong Zhang; Mirko Manetti; Marco Matucci-Cerinic
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-05-06       Impact factor: 5.346

Review 8.  Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis.

Authors:  Jiangfan Yu; Rui Tang; Ke Ding
Journal:  Int J Gen Med       Date:  2022-03-19

Review 9.  Unraveling SSc Pathophysiology; The Myofibroblast.

Authors:  Arjan van Caam; Madelon Vonk; Frank van den Hoogen; Peter van Lent; Peter van der Kraan
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

10.  Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers.

Authors:  Katarzyna Wolska-Gawron; Joanna Bartosińska; Marta Rusek; Małgorzata Kowal; Dorota Raczkiewicz; Dorota Krasowska
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.